Reversal of endothelial dysfunction in humans

Coronary Artery Disease

Volumn 12, Issue 6, 2001, Pages 463-473

  Hornig, B ^a   Drexler, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Coronary artery disease; Endothelium; Nitric oxide

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA TOCOPHEROL; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIOXIDANT; ARGININE; ASCORBIC ACID; COLESTYRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; LOSARTAN; NITRIC OXIDE SYNTHASE; PROBUCOL; RAMIPRIL; RENIN; SPIRONOLACTONE; STATIN; TETRAHYDROBIOPTERIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ADHESION; CLINICAL TRIAL; DRUG EFFECT; ENDOTHELIUM LESION; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; LOW FAT DIET; MONOCYTE; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE;

EID: 0034763524     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200109000-00005     Document Type: Review

References (106)

1. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling
2. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
3. Effects of vitamin E on chronic and acute endothelial dysfunction in smokers
4. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
5. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion
6. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury
7. Angiotensin stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
8. Antiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation
9. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for the involvement of the renin-angiotensin system
10. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase
11. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis
12. Functional improvement precedes structural regression of atherosclerosis
13. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients
14. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
15. The effect of cholesterol lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
16. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both
17. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipirydamol in patients with coronary artery disease - A potential noninvasive marker of healing coronary endothelium
18. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels
19. Increased bioavailibility of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients
20. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month
21. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
22. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men
23. Effect of a single high-fat meal on endothelial function in healthy subjects
24. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans
25. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
26. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease
27. The effect of Pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
28. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
29. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus revascularization treatment investigators
30. Suppression of angiotensin-converting enzyme expression by shear stress
31. Effect of captopril on mortality and morbitiy in patients with left ventricular dysfunction after myocardial infarctions: Results of the survival and ventricular enlargement trial
32. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions
33. Effect of ramipril on mortality and morbitiy of survivors of acute mycardial infarction with clinical evidence of heart failure
34. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
35. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease
36. Role of bradykinin in mediating vascular effects of ACE-inhibitors in humans
37. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure
38. Comparative study of ACE-inhibition, angiotensin-II antagonism and calcium-channel blockade on flow-mediated vasodilation in patients with coronary artery disease (BANFF-study)
39. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects
40. Role of endogenous bradykinin human coronary vasomotor control
41. Comparative effect of ACE-inhibition and angiotensin II-type 1-receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease - Role of superoxide dismutase
42. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis
43. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction betweeen the renin-angiotensin system and fibrinolytic function
44. Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin
45. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies
46. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis
47. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes
48. Angiotensin I type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
49. AT2 receptor stimulation increases aortic cyclic cGMP in SHRSP by a kinin-dependent mechanism
50. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure
51. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
52. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure
53. Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1β
54. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients
55. Endothelial control of arterial distensibility is impaired in chronic heart failure
56. Flow-dependent coronary artery vasodilation in humans
57. Flow-mediated arteriolar dilation is abnormal in congestive heart failure
58. Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow
59. Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries
60. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase
61. Physical training improves endothelial function in patients with chronic heart failure
62. Both physical fitness and acute exercise regulate nitric oxide formation in healthy humans
63. Training improves endothelium-dependent vasodilation in resistance vessels of patients with chronic heart failure
64. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure
65. Effect of exercise on coronary endothelial function in patients with coronary artery disease
66. Exercise training increases basal nitric oxide production from the forearm of hypercholesterolemic patients
67. Regular aerobic exercise augments endothelium-dependent vascular relaxations in normotensive as well as in hypertensive subjects: Role of endothelium-derived nitric oxide
68. Regulation of extracellular superoxide dismutase my nitric oxide in vascular smooth muscle
69. Increased angiotensin-I converting enzyme gene expression in the failing human heart
70. Reduction of coronary atherosclerosis by moderate conditioning exercise in monkeys on an atherogenic diet
71. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease
72. Correction of endothelial dysfunction in the coronary microcirculation of hypercholesterolemic patients by L-arginine
73. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation
74. Aging-associated endothelial dysfunction in humans is reversible by L-arginine
75. Effects of L-arginine supplementation in patients with angina pectoris and normal coronary arteries
76. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults
77. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans
78. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease
79. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with chronic heart failure
80. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure
81. Dietary supplementation with L-arginine fails to restore endothelial function in the forearm resistance arteries of patients with severe heart failure
82. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men
83. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans
84. Cellular and molecular mechanisms of endothelial cell dysfunction
85. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits
86. Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction
87. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure
88. Plasma levels of ADMA are increased and inversely related to endothelium-mediated vasodilation in patients with chronic heart failure; a new predictor of endothelial function
89. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase
90. Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase
91. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia
92. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease
93. Vitamin C improves endothelial function in patients with chronic heart failure
94. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers
95. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in patients with essential hypertension
96. Long-term ascorbic acid reverses endothelial dysfunction in patients with coronary artery disease
97. Treatment of hypertension with ascorbic acid
98. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion
99. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia
100. Tetrahydrobiopterin restores endothelial function in long-term smokers
101. Plasma tocopherol and coronary endothelium-dependent vasodilator function
102. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia
103. Estrogens, progestins and coronary artery reactivity. Certain progestins may oppose the favorable effect of estrogen on the cardiovascular system in potmenopausal women
104. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. HEARS Research group